AsthmaVent - Effect of Mechanical Ventilation on Asthma Control in Children
AsthmaVent
1 other identifier
interventional
46
1 country
7
Brief Summary
AsthmaVent is a multi-center study, investigating the association between indoor air quality and childhood asthma. In Denmark, we spend more and more time indoors. Our houses are built airtight to save energy and are difficult to ventilate. We are thus more exposed to our indoor air than ever before. We know that indoor air contains many different components that can affect our airways inappropriately and particularly children with asthma, who have sensitive airways are sensitive to these components. The AsthmaVent project examines whether increased ventilation is able to improve the indoor environment to such an extent that the asthma disease control, for children with asthma and house dust mite allergy improves, resulting in need for less medication. Previous studies have pointed towards a beneficial effect of mechanical ventilation, on both the indoor air quality and on children's health and quality of life. There is not currently a consensus in this area, as studies so far have not been large or good enough to confidently determine the effect. This project is big and is designed so that it takes into account the sources of error seen in previous studies on the topic. We include, over a 3-year period (2012-2014), a total of 80 children with asthma and house dust mite allergy aged 6-18 years, from pediatric departments in Aarhus, Odense, Kolding, Randers and Herning. They are divided into two groups, receiving either active ventilation or placebo ventilation, meaning a non-functioning ventilation system that just recirculates the air in the room. Ventilation systems are installed in the fall and winter and ventilate the child's bedroom during 9 months. Indoor air quality and asthma control are assessed every 3 months, both at home visits were air quality and allergen levels of house dust mites are studies and at visits to the outpatient clinics with control of asthma parameters and quality of life. The project involves collaboration between several institutions with an interest in indoor air quality in relation to allergies and asthma and with great expertise in the field.The project was initiated by CISBO (Centre for Indoor Environment and Health in Dwellings), a center consisting of several institutions in Denmark dealing with indoor environment: Department of Public Health at Aarhus University and University of Copenhagen, Danish Building Research Institute and the Technical University of Denmark. Since asthma is the most common chronic childhood disease in Denmark and since the development of allergies and asthma has high social and personal costs, it is important for both society and the individual family, to find out whether simply improving the indoor air quality by increased ventilation can lead to an improvement in asthma disease control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2012
Longer than P75 for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 19, 2014
CompletedFirst Posted
Study publicly available on registry
February 21, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedMay 12, 2016
May 1, 2016
3.5 years
February 19, 2014
May 11, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in dose of inhaled corticosteroid
Measured in micrograms of a specific inhaled corticosteroid
Baseline, 3 months, 6 months and 9 months
Changes in particle concentration in child bedroom
Measured as particles pr. m3
baseline, 3 months, 6 months and 9 months
Secondary Outcomes (9)
FEV1
Baseline, 3,6 and 9 months
FeNO
Baseline, 3,6 and 9 months
Quality of Life
Baseline, 3,6 and 9 months
Standard Skin-prick-test and Specific IgE- phadiatop
Baseline and 9 months
Asthma Symptoms
During 14 days at baseline, 3, 6 and 9 months
- +4 more secondary outcomes
Study Arms (2)
Ventilation
ACTIVE COMPARATORIncreased ventilation in the childs bedroom to at least 2-3 air changes pr hour.
Placebo ventilation
PLACEBO COMPARATORVentilation system that recirculates the air in the childs bedroom
Interventions
The ventilation system is placed outside the house and provides filtered conditioned air to the child's bedroom, through insulated pipes mounted in a window opening. The window opening was built specifically for this purpose in form of a thermo plate replacing the window glass. The unit provides the bedroom with at least 2-3 air changes per hour
The placebo unit (DUPLEX 370) is a completely similar installation to the active ventilation unit, but it only recirculates the air in the room instead of replacing it with fresh conditioned air.
Eligibility Criteria
You may qualify if:
- Doctors diagnosed asthma
- Need of inhaled steroid titrated down to at least 400 microg/day of Budesonide or equivalent dose of other corticosteroid
- Skin prick test \>/= 3 mm or specific IgE \>/= 0,7 kU/l to house dust mites (Derm. Pteronyssinus and/or Derm. Farinae)
- more than 500 nanog/gr dust of house dust mite allergen in the childs mattress.
- Living in a one-family house and will allow changes of the house during the intervention period.
- Capable of giving informed consent.
You may not qualify if:
- Other clinically relevant allergies to tree pollen or animals present in the house.
- Other diseases or treatments, as for example immunotherapy, which could influence the results.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Børneafdelingen Herlev Hospital
Herlev, Capital Region, 2730, Denmark
Childrens Department, Aarhus University Hospital
Aarhus, Region Midt, 8200, Denmark
Childrens Department, Herning Hospital
Herning, Region Midt, 7400, Denmark
Childrens DEpartment, Randers Hospital
Randers, Region Midt, 8930, Denmark
Childrens Department, Hillerød hospital
Hillerød, Region Nordsjælland, 3400, Denmark
Childrens Department, Kolding Hospital
Kolding, Region Syddanmark, 6000, Denmark
H.C. Andersens Children Hospital, Odense University Hospital
Odense, Region Syddanmark, 5000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Torben Sigsgaard, Professor
Aarhus University, Department of Public Health, Section for Environment, Occupation and Health
- PRINCIPAL INVESTIGATOR
Nina V Hogaard, MD
Aarhus University, Dept. of Public Health, Section for Environment, Occupation and Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 19, 2014
First Posted
February 21, 2014
Study Start
August 1, 2012
Primary Completion
February 1, 2016
Study Completion
February 1, 2016
Last Updated
May 12, 2016
Record last verified: 2016-05